4th International Symposium on Cancer Metastasis and the Lymphovascular System

第四届癌症转移与淋巴血管系统国际研讨会

• 批准号: 8126650
• 负责人: STANLEY P L LEONG
• 金额: $ 0.3万
• 依托单位: CALIFORNIA PACIFIC MED CTR RES INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-04-01 至 2012-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8126650
• 关键词: Address; Advisory Committees; Age; American; Area; Award; Basic Science; Biological Markers; Books; Cancer Patient; Clinical Oncology; Clinical Trials; Diagnosis; Directories; Distant; Doctor of Philosophy; Electronic Mail; Faculty; Future; Genomics; Goals; Image; Individual; International; Investigation; Letters; Lymphovascular; Malignant Neoplasms; Medical; Medical Education; Minority; Molecular; Neoplasm Metastasis; New York City; Operative Surgical Procedures; Oral; Postdoctoral Fellow; Process; Published Directory; Recruitment Activity; Research; Research Personnel; Scientist; Sentinel Lymph Node; Site; Social Environment; Students; Subgroup; System; Time; United States; Woman; abstracting; anticancer research; base; cancer therapy; career; clinical application; graduate student; innovation; interest; lectures; medical schools; melanoma; posters; programs; symposium; treatment strategy

DESCRIPTION (provided by applicant): There will be a total of 9 main sessions in the 4th International Symposium on Cancer Metastasis and the Lymphovascular System: Basis for Rational Therapy to be held from May 13-14, 2011 in New York City. A mini-symposium on Progression of Malignant Melanoma: Implications for Treatment will be held in the evening preceding the symposium. The 9 sessions will be enhanced by 3 distinguished lectures. These sessions and distinguished lectures will demonstrate that cancer metastasis is a progressive process from the primary site to the distant sites, oftentimes, via the gateway of the sentinel lymph nodes. Cancer patients can be classified into separate subgroups based on genomic profiles and biomarkers, with implications for future research and evolving treatment strategies. Biomarkers will be thoroughly examined for their ability to define cancer metastasis and as targets for specific imaging and therapy. A translational dialogue will be promoted between basic scientists and clinicians so that a bridge can be built between understanding the molecular mechanisms of cancer metastasis and clinical application of basic science in curbing the process of cancer spread. The innovative approach of this symposium is the emphasis to raise unanswered questions from the panel discussions to generate new hypotheses for future investigations and clinical trials. Using the theme of the symposium that cancer metastasis is a critical topic of cancer research and treatment; we want to develop a robust Young Investigator and Trainee Award Program to allow young investigators and trainees with interest in cancer metastasis to participate actively in the symposium. PUBLIC HEALTH RELEVANCE: In the United States, one of four Americans will be diagnosed with cancer and in about 50% of them, their cancer may spread, which will threaten their lives. The 4th International Symposium on Cancer Metastasis and the Lymphovascular System: Basis for Rational Therapy to be held from May 12-14, 2011 in New York City will address this urgent problem in clinical oncology with the major theme to describe the utility of biomarkers to track cancer spread and as targets for therapy. An effort has been made to attract young investigator and trainees to develop their career interest in cancer metastasis.

描述（由申请人提供）：第四届国际癌症转移和淋巴血管系统：合理治疗的基础研讨会将于2011年5月13日至14日在纽约举行，共有9个主要会议。恶性黑色素瘤的进展：对治疗的影响将在研讨会前的晚上举行一个小型研讨会。9节课将有3位杰出的讲座。这些会议和杰出的讲座将证明癌症转移是一个从原发部位到远处部位的渐进过程，通常是通过前哨淋巴结的门户。癌症患者可以根据基因组图谱和生物标志物分为不同的亚组，这对未来的研究和不断发展的治疗策略具有重要意义。生物标志物将被彻底检查，以确定癌症转移的能力，并作为特定成像和治疗的目标。促进基础科学家和临床医生之间的转化对话，以便在了解癌症转移的分子机制和基础科学在抑制癌症扩散过程中的临床应用之间建立桥梁。本次研讨会的创新之处在于强调从小组讨论中提出未解决的问题，为未来的研究和临床试验提出新的假设。利用研讨会的主题：肿瘤转移是癌症研究和治疗的重要课题；我们希望建立一个健全的青年研究者和实习生奖励计划，让对癌症转移感兴趣的年轻研究者和实习生积极参与研讨会。